Eugenia Kuo

Columbia University

Papers

1

Total Citations

61

H-Index

1

About

Eugenia Kuo is a leading voice in health policy and medical ethics, with a focused research agenda on the intersection of technology, marketing, and patient safety in surgical care. Her most influential work critically examines the commercialization of robotic surgery, particularly in gynecologic procedures. In her landmark 2012 study, "The commercialization of robotic surgery: unsubstantiated marketing of gynecologic surgery by hospitals," which has garnered 61 citations, Kuo exposed how hospitals often promote robotic surgery through unsubstantiated claims of superior outcomes, despite limited evidence of benefit over traditional approaches. This work has been instrumental in shaping policy discussions around direct-to-consumer medical advertising and informed consent. Kuo’s research empowers patients and clinicians to navigate the hype surrounding new surgical technologies, emphasizing evidence-based decision-making. Her contributions have been widely recognized for their impact on healthcare transparency, making her a respected authority on the ethical implications of medical innovation. For students and researchers, Kuo’s work serves as a critical reminder to question market-driven narratives in medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
61
Total Citations
61
Avg Citations/Paper
🏆 Most Cited Paper
The commercialization of robotic surgery: unsubstantiated marketing of gynecologic surgery by hospitals
61 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Columbia University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago